N-stearamide was a potential biomarker for disordered fatty acid metabolism related to hepatic cirrhosis [34], whereas PEA was a ligand of peroxisome proliferator-activated receptors (PPAR-α) that exerted neuroprotective, anti-inflammatory, analgesic, and lipid-regulating effects [35,36]. This evidence concerns the gene PPARA and Cirrhosis.